US BANCORP \DE\ - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 2 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$1,000
-83.3%
2,000
-80.0%
0.00%
Q2 2022$6,000
-45.5%
10,0000.0%0.00%
Q1 2022$11,000
-26.7%
10,000
+990.5%
0.00%
Q3 2018$15,0009170.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders